Discover 2,122 paid clinical trials in Allentown, Pennsylvania. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 2,122
The Gender Inclusive Sexuality Talks Program
for
HIV/STI Incidence, Communication About Health Information
Location: Philadelphia PA
Sponsor: University of Pennsylvania
Sex: All
Age: 12 - 70+
Code: NCT07825571
Recruiting
This Study Will Evaluate the Effectiveness of NTX-001, a Surgical Nerve Repair Product When Used in People With Upper Extremity Nerve Lacerations.
for
Peripheral Nerve Injury Upper Limb,
Location: Philadelphia PA, Camden NJ, New York NY, Baltimore MD,
Sponsor: Neuraptive Therapeutics Inc.
Sex: All
Age: 18 - 70+
Code: NCT06616025
Phase 3, Recruiting
Use of Digital Tomosynthesis for Detection and Case Management of Scaphoid and Distal Radius Fractures: A VolumeRAD Data Collection Study
for
Distal Radius Fracture, Scaphoid Fracture
Location: Philadelphia PA
Sponsor: GE Healthcare
Sex: All
Age: 18+
Code: NCT03856450
Recruiting
A Study to Determine the Role of Toll-like Receptor-4 Expression in Patients With Interstitial Cystitis/Bladder Pain Syndrome
for
Cystitis, Interstitial, Painful Bladder Syndrome
Location: Philadelphia PA
Sponsor: Philadelphia Urosurgical Associates
Sex: Female
Age: 18 - 70+
Code: NCT02868775
Recruiting
A Long-term Study of the Safety and Effectiveness of RAP-219 in Adults With Focal Onset Seizures
Location: Philadelphia PA, New York NY, Cleveland OH,
Sponsor: Rapport Therapeutics Inc.
Sex: All
Age: 18 - 70
Code: NCT07219407
Phase 2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Lung Injury is One of the Primary Causes of Morbidity and Mortality in Critically Ill Patients. These Patients Will be Monitored for: 1) Immune Cell Activation 2) Blood-based Biomarkers. In Vitro Models Derived From These Samples Will be Treated With Novel Agent PIP-2 to Evaluate Its Efficacy.
for
ARDS (Acute Respiratory Distress Syndrome)
Location: Philadelphia PA
Sponsor: University of Pennsylvania
Sex: All
Age: 21 - 70+
Code: NCT07125079
Recruiting
Identification of Breast Cancer in Breath Samples Using Trained Detection Dogs
for
Breast Cancer
Location: Philadelphia PA, Totowa NJ
Sponsor: SpotitEarly
Sex: Female
Age: 18+
Code: NCT07038785
Recruiting
A Study of (LY3527727) Pirtobrutinib in Participants With Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma or Non-Hodgkin Lymphoma
Location: Philadelphia PA, New York NY, Lake Success NY,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18+
Code: NCT06876662
Recruiting
A Study of Raludotatug Deruxtecan (R-DXd) in Subjects With Platinum-resistant, High-grade Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
for
Solid Cancer
Location: Philadelphia PA, Paramus NJ, Teaneck NJ, New York NY,
Sponsor: Daiichi Sankyo
Sex: All
Age: 18+
Code: NCT06161025
Phase 2, Phase 3, Recruiting
A Study of Nipocalimab or Intravenous Immunoglobulin (IVIG) in Pregnancies At Risk of Fetal and Neonatal Alloimmune Thrombocytopenia (FNAIT)
for
Thrombocytopenia, Neonatal Alloimmune
Location: Philadelphia PA, Rochester NY, Chapel Hill NC,
Sponsor: Janssen Research & Development, LLC
Sex: Female
Age: 18 - 45
Code: NCT06533098
Phase 3, Recruiting
A Study of Dotinurad Versus Allopurinol in Tophaceous Gout
for
Tophaceous Gout
Location: Sparta NJ, Brooklyn NY, Oradell NJ, New York NY,
Sponsor: Crystalys Therapeutics
Sex: All
Age: 18 - 70+
Code: NCT07089888
Phase 3, Recruiting
TLN-121 in Relapsed or Refractory Non-Hodgkin Lymphomas
for
Lymphoma, Lymphoma, Non Hodgkin
Location: Philadelphia PA, New York NY, Grand Rapids MI,
Sponsor: Treeline Biosciences, Inc.
Sex: All
Age: 18+
Code: NCT07082803
Phase 1, Recruiting
A Study to Investigate the Safety, Tolerability, and Efficacy of SAR446268, an Adeno-associated Viral Vector-mediated Gene Therapy in Participants Aged 10 to 55 Years of Age With Non-congenital Myotonic Dystrophy Type 1
for
Myotonic Dystrophy
Location: Philadelphia PA, New York NY, Richmond VA, Montreal,
Sponsor: Sanofi
Sex: All
Age: 10 - 55
Code: NCT06844214
Phase 1, Phase 2, Recruiting
Pharmacogenetics of Response to GLP1R Agonists
for
Obesity, Diabetes Type 2
Location: Lancaster PA
Sponsor: University of Maryland, Baltimore
Sex: All
Age: 18 - 70+
Code: NCT05071898
Phase 1, Recruiting
A Master Protocol to Evaluate the Long-Term Safety of (LY3527727) Pirtobrutinib